Scholarly Index
Laura Rosiñol
Hospital Clínic de Barcelona; 28,047 total citations; 509 total publications; best world rank #59
Hospital Clínic de Barcelona
28,047Total citations
509Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Multiple Myeloma Research and Treatments | Lifetime | 110 | ES 8 | 99.26 |
| Protein Degradation and Inhibitors | Lifetime | 115 | ES 6 | 98.97 |
| Peptidase Inhibition and Analysis | Lifetime | 291 | ES 8 | 98.80 |
| Cancer Treatment and Pharmacology | Lifetime | 472 | ES 13 | 98.67 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 246 | ES 6 | 96.93 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 761 | ES 26 | 94.97 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 59 | ES 7 | 99.20 |
| Protein Degradation and Inhibitors | 2021-2025 | 64 | ES 6 | 98.51 |
| Peptidase Inhibition and Analysis | 2021-2025 | 123 | ES 10 | 96.99 |
| Cancer Treatment and Pharmacology | 2021-2025 | 181 | ES 15 | 96.49 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 498 | ES 24 | 89.34 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 435 | ES 20 | 86.12 |